Combinatorial treatment with menin and FLT3 inhibitors induces complete remission in AML models with activating FLT3 mutations
Hongzhi Miao, Eungi Kim, Dong Chen, Trupta Purohit, Katarzyna Kempińska, James Ropa, Szymon Kłossowski, Winifred Trotman, Gwenn Danet-Desnoyers, Tomasz Cierpicki, Jolanta Grembecka
Topics & Concepts
Complete remissionVenetoclaxCancer researchMutationFms-Like Tyrosine Kinase 3MedicineAzacitidineLeukemiaOncologyInternal medicineBiologyGeneticsGeneChemotherapyGene expressionChronic lymphocytic leukemiaDNA methylationAcute Myeloid Leukemia ResearchProtein Degradation and InhibitorsMultiple Myeloma Research and Treatments